Dec 29, 2023
1:240
For every 240 shares held, investors received 1. The price per share adjusted from $0.04 to $0.00.
The split itself did not change the total investment value.
Avalo Therapeutics, Inc. (AVTX) trades on the NASDAQ Capital Market in the Biotechnology industry.
Avalo Therapeutics, Inc. company overviewThe latest split shown was on December 29, 2023. It was a 1-for-240 reverse split, so shareholders received 1 share for every 240 they held.
This history records 2 reverse splits between July 8, 2022 and December 29, 2023.